[HTML][HTML] High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
…, K Hawkins, J Brown, MT Drayson… - … England Journal of …, 2003 - Mass Medical Soc
Background High-dose therapy with supporting autologous stem-cell transplantation remains
a controversial treatment for cancer. In multiple myeloma, first-line regimens incorporating …
a controversial treatment for cancer. In multiple myeloma, first-line regimens incorporating …
Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T‐cell subset
…, Y Zheng, MD Kilby, DM Sansom, MT Drayson - …, 2004 - Wiley Online Library
CD4 + CD25 + T regulatory cells (T Reg ), suppress antigen‐specific immune responses
and are important for allograft tolerance. During pregnancy the mother tolerates an allograft …
and are important for allograft tolerance. During pregnancy the mother tolerates an allograft …
Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine
…, GP Mead, LX Tang, PJ Showell, MT Drayson… - Clinical …, 2001 - academic.oup.com
Background: Bence Jones proteins or monoclonal immunoglobulin κ and λ free light chains (FLCs)
are important markers for identifying and monitoring many patients with B-cell tumors. …
are important markers for identifying and monitoring many patients with B-cell tumors. …
Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma
…, WM Gregory, A Quartilho, MT Drayson… - Journal of clinical …, 2015 - ascopubs.org
Purpose At the molecular level, myeloma is characterized by copy number abnormalities and
recurrent translocations into the immunoglobulin heavy chain locus. Novel methods, such …
recurrent translocations into the immunoglobulin heavy chain locus. Novel methods, such …
[HTML][HTML] First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
…, SE Bell, AJ Szubert, N Navarro-Coy, MT Drayson… - The Lancet, 2010 - thelancet.com
Background Bisphosphonates reduce the risk of skeletal events in patients with malignant
bone disease, and zoledronic acid has shown potential anticancer effects in preclinical and …
bone disease, and zoledronic acid has shown potential anticancer effects in preclinical and …
Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002 …
…, J Behrens, A Smith, JA Child, MT Drayson - Journal of clinical …, 2005 - ascopubs.org
Purpose Early mortality in multiple myeloma (MM) is usually attributed to combined effects
of active disease and comorbid factors. We have studied early deaths in a series of large …
of active disease and comorbid factors. We have studied early deaths in a series of large …
[PDF][PDF] Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX …
…, SE Bell, AJ Szubert, N Navarro-Coy, MT Drayson… - J Clin …, 2013 - researchgate.net
… In intensive-pathway patients, adverse interphase fluorescence in situ hybridization
cytogenetic profiles were defined as gain(1q), del(1p32), t(4;14), t(14;20), t(14;16), and del(17p) …
cytogenetic profiles were defined as gain(1q), del(1p32), t(4;14), t(14;20), t(14;16), and del(17p) …
Serum test for assessment of patients with Bence Jones myeloma
…, HD Carr-Smith, GP Mead, TC Harvey, MT Drayson - The Lancet, 2003 - thelancet.com
… M Drayson and A Bradwell designed the study and selected the patients. Collection, storage,
and availability of the samples was via MT Drayson. T Harvey provided information on the …
and availability of the samples was via MT Drayson. T Harvey provided information on the …
The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis
…, C Rudin, H Roddie, MT Drayson… - Blood, The Journal …, 2012 - ashpublications.org
Thalidomide maintenance has the potential to modulate residual multiple myeloma (MM)
after an initial response. This trial compared the effect of thalidomide maintenance and no …
after an initial response. This trial compared the effect of thalidomide maintenance and no …
How I treat monoclonal gammopathy of renal significance (MGRS)
Recently, the term monoclonal gammopathy of renal significance (MGRS) was introduced to
distinguish monoclonal gammopathies that result in the development of kidney disease …
distinguish monoclonal gammopathies that result in the development of kidney disease …